Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Aveanna Healthcare Holdings Inc. (AVAH) has a Wall Street consensus price target of $11.17, based on estimates from 12 covering analysts. With the stock currently trading at $7.36, this represents a potential upside of +51.8%. The company has a market capitalization of $1.53B.
Analyst price targets range from a low of $9.50 to a high of $13.00, representing a 31% spread in expectations. The median target of $11.00 aligns closely with the consensus average.
The current analyst consensus rating is Hold, with 5 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, AVAH trades at a trailing P/E of -129.8x and forward P/E of 12.2x. Analysts expect EPS to grow +586.5% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how AVAH stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for AVAH is $11.17, representing 51.8% upside from the current price of $7.36. With 12 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
AVAH has a consensus rating of "Hold" based on 12 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $11.17 implies 51.8% upside from current levels.
With a forward P/E of 12.1552x, AVAH trades at a relatively low valuation. The consensus target of $11.17 implies 51.8% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $13 for AVAH, while the most conservative target is $9.5. The consensus of $11.17 represents the median expectation. These targets typically reflect 12-month expectations.
AVAH is moderately covered, with 12 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 6 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AVAH stock forecast based on 12 Wall Street analysts shows a consensus price target of $11.17, with estimates ranging from $9.5 (bear case) to $13 (bull case). The median consensus rating is "Hold".
AVAH trades at a forward P/E ratio of 12.2x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on AVAH, with a "Hold" consensus rating and $11.17 price target (51.8% upside). 5 of 12 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AVAH analyst price targets range from $9.5 to $13, a 31% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $11.17 consensus represents the middle ground.